152 related articles for article (PubMed ID: 22996285)
1. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer.
Meng JR; Tang HZ; Zhou KZ; Shen WH; Guo HY
Clin Exp Med; 2013 Nov; 13(4):297-303. PubMed ID: 22996285
[TBL] [Abstract][Full Text] [Related]
2. Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.
Ding A; Zhao W; Shi X; Yao R; Zhou F; Yue L; Liu S; Qiu W
PLoS One; 2013; 8(12):e82136. PubMed ID: 24358147
[TBL] [Abstract][Full Text] [Related]
3. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
[TBL] [Abstract][Full Text] [Related]
4. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
5. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.
Dhar DK; Wang TC; Tabara H; Tonomoto Y; Maruyama R; Tachibana M; Kubota H; Nagasue N
Clin Cancer Res; 2005 Sep; 11(18):6472-8. PubMed ID: 16166422
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.
Taniguchi Y; Kurokawa Y; Takahashi T; Mikami J; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2018 Dec; 42(12):3997-4004. PubMed ID: 30039286
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.
Im S; Yoo C; Jung JH; Choi HJ; Yoo J; Kang CS
Int J Med Sci; 2013; 10(2):133-40. PubMed ID: 23329884
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.
Zhang CX; Wu CT; Xiao L; Tang SH
Biomarkers; 2021 Mar; 26(2):95-102. PubMed ID: 33401971
[TBL] [Abstract][Full Text] [Related]
9. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor C and survivin in gastric carcinoma and their clinical implications].
Sun YS; Ye ZY; Zhao ZS; Shi D; Zou SC
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):264-7. PubMed ID: 16721694
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
[TBL] [Abstract][Full Text] [Related]
12. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.
Miyachi K; Sasaki K; Onodera S; Taguchi T; Nagamachi M; Kaneko H; Sunagawa M
Gastric Cancer; 2003; 6(4):217-24. PubMed ID: 14716515
[TBL] [Abstract][Full Text] [Related]
13. Differences between gastric signet-ring cell carcinoma and poorly differentiated adenocarcinoma: A comparison of histopathologic features determined by mucin core protein and trefoil factor family peptide immunohistochemistry.
Fujimoto A; Ishikawa Y; Ishii T; Yamada A; Igarashi Y; Ohmoto Y; Kaise M
Pathol Int; 2017 Aug; 67(8):398-403. PubMed ID: 28691258
[TBL] [Abstract][Full Text] [Related]
14. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.
Deng JY; Sun D; Liu XY; Pan Y; Liang H
World J Gastroenterol; 2010 Nov; 16(42):5380-7. PubMed ID: 21072904
[TBL] [Abstract][Full Text] [Related]
15. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
16. TFF3 and HER2 expression and their correlation with survival in gastric cancer.
Gu J; Zheng L; Zhang L; Chen S; Zhu M; Li X; Wang Y
Tumour Biol; 2015 Apr; 36(4):3001-7. PubMed ID: 25514872
[TBL] [Abstract][Full Text] [Related]
17. Expression of survivin and caspase-3 in gastric cancer.
Kania J; Konturek SJ; Marlicz K; Hahn EG; Konturek PC
Dig Dis Sci; 2003 Feb; 48(2):266-71. PubMed ID: 12643601
[TBL] [Abstract][Full Text] [Related]
18. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
[TBL] [Abstract][Full Text] [Related]
19. Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels.
Zhang J; Zhu Z; Sun Z; Sun X; Wang Z; Xu H
Mol Med Rep; 2014 Feb; 9(2):600-6. PubMed ID: 24337012
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma.
Shintani M; Sangawa A; Yamao N; Kamoshida S
Int J Clin Exp Pathol; 2013; 6(12):2919-27. PubMed ID: 24294379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]